sucujovide.wordpress.com
The private, nonprofit group’s role in the May 18-221 conference, which is beinf held for the first time in the indicates how the organization has grown and expanded its scopw since it beganin 1989. It follows a move to re-inventg itself that was marked with changing its name last year from the Georgia Biomedical Partnership toGeorgia Bio. “We felt that with the name GeorgiasBiomedical Partnership, people only thought that we were promoting the interesyt of the companies and organizations involved in applying life sciences technologyt to biomedicine,” said Charles president of Georgia Bio.
The nonprofit’s membershilp has doubled in the past five years to some 300 including pharmaceutical, biotech and medical device companies, as well as research institutes, government groups and businesses. They range in expertise from health care and agriculture to industriakl and bioenergy production andenvironmental management. “Whenm it comes to the life science all applications of it are represented herein Georgia,” Crai said.
Board members represent some ofthe state’ws largest life sciences companies, such as , , and and , and emergingt firms such as The groupl works to represent and promote the interes t of the life sciences in Georgia Bio is serving on the frontline in preparationh for BIO 2009, said Fabrice Egros, presideng of Atlanta-based biopharmaceutical company UCB, the Nortnh American subsidiary for Brussels-based UCB S.A. The conferences is expected to bring morethan 20,0009 people from 70 nationss and 48 states. As the state affiliate for the Biotechnologt Industry Organization and a member of the Council of StatBioscience Associations, Georgia Bio is the conference’s local host.
co-chairman of the board for Georgia Bio, said the 2009 conventio is important to Georgias becoming a leader inlife “BIO is one step,” he “That’s where we will create the awareness of Georgiaa ... companies in our care.”
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment